| Literature DB >> 29286271 |
Ziyad M Hijazi1, Damien Kenny2.
Abstract
CHD affects millions of patients worldwide. Interventional therapies for CHD goes back to the mid-1960s when Bill Rashkind performed balloon atrial septostomy on a cyanotic baby with transposition of the great vessels. This was followed by development of balloon catheters to perform balloon valvuloplasties and angioplasties in the early to late 1980s. Although King and Mills performed the first transcatheter closure of secundum atrial septal defect in the mid-1970s, this procedure was better realised in the mid-1990s. More intracardiac defect closures were performed in the late 1990s and early 2000. This brings us to the current era of percutaneous valve implantation as developed by Bonhoeffer. In this paper, we will discuss the past, present, and future of interventional cardiac catheterisation for CHD patients.Entities:
Keywords: Cardiac catheterization; congenital heart disease; transcatheter pulmonary valve replacement
Mesh:
Year: 2017 PMID: 29286271 DOI: 10.1017/S1047951117002141
Source DB: PubMed Journal: Cardiol Young ISSN: 1047-9511 Impact factor: 1.093